The Food and Drug Administration on Thursday formally approved Juul to sell its vape devices and nicotine pods. Dr. Robert ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Amazon.com Inc.’s carbon emissions rose for the first time in three years in 2024, driven by data center construction and ...

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...

U.S. President Donald Trump has announced that China may soon implement the death penalty for those involved in fentanyl ...

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...